The Impact of Gut Microbiome in Clinical Neurological Conditions

Date/Time: Monday, October 24, 2022 - 12:00 PM – 1:00 PM
Track: Interactive Lunch Workshop
Log in to Add to My Schedule


Increasing clinical and preclinical evidence implicates the microbiome as a possible key susceptibility factor for neurological disorders, including Alzheimer's disease, autoimmune disorders, multiple sclerosis, Parkinson's disease, and stroke. Cross-sectional clinical studies are bolstering the concept of altered microbial composition contributing to the pathophysiology of neurological disorders. However, the field is nascent, and interpretation of such data is often difficult given that the composition of the microbiome is influenced by various factors such as diet and exercise.  

Chair: Beau Ances, MD, PhD, MSc, FANA

Co-Chair: Louise McCullough, MD, PhD, FANA


  • Learners will understand that there is a gut brain axis and that there are potential early changes in the gut microbiome and that these can be modified.

Neurodegenerative Diseases and the Gut Microbiome  


The Gut Microbiome in Parkinson's Disease


Stroke and the Microbiome